Edition:
United Kingdom

SanBio Co Ltd (4592.T)

4592.T on Tokyo Stock Exchange

3,950JPY
18 Jan 2018
Change (% chg)

¥165 (+4.36%)
Prev Close
¥3,785
Open
¥3,775
Day's High
¥4,195
Day's Low
¥3,745
Volume
1,211,600
Avg. Vol
620,503
52-wk High
¥4,195
52-wk Low
¥1,012

Chart for

About

SanBio Company Limited is a Japan-based company primarily engaged in the research and development of regenerative cells drugs. The Company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular... (more)

Overall

Beta: --
Market Cap(Mil.): ¥83,119.16
Shares Outstanding(Mil.): 45.42
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 85.75 16.58
EPS (TTM): -- -- --
ROI: -- 3.21 10.60
ROE: -- 4.54 14.19

BRIEF-SanBio and unit receives subsidy of $4.1 mln from CIRM

* Says it and unit, SanBio, Inc., received subsidy of $4.1 million from CIRM, on Dec. 13 (the U.S. time)

14 Dec 2017

BRIEF-SanBio signs commitment line agreement worth 1.6 bln yen

* Says it signs a commitment line agreement worth 1.6 billion yen on Aug. 21, with a term from Aug. 21 to July 31, 2021

21 Aug 2017

Earnings vs. Estimates